These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10792129)

  • 1. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.
    Somasundaram S; Sigthorsson G; Simpson RJ; Watts J; Jacob M; Tavares IA; Rafi S; Roseth A; Foster R; Price AB; Wrigglesworth JM; Bjarnason I
    Aliment Pharmacol Ther; 2000 May; 14(5):639-50. PubMed ID: 10792129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.
    Mahmud T; Somasundaram S; Sigthorsson G; Simpson RJ; Rafi S; Foster R; Tavares IA; Roseth A; Hutt AJ; Jacob M; Pacy J; Scott DL; Wrigglesworth JM; Bjarnason I
    Gut; 1998 Dec; 43(6):775-82. PubMed ID: 9824604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat.
    Sigthorsson G; Jacob M; Wrigglesworth J; Somasundaram S; Tavares I; Foster R; Roseth A; Rafi S; Mahmud T; Simpson R; Bjarnason I
    Scand J Gastroenterol; 1998 Jul; 33(7):728-35. PubMed ID: 9712237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism.
    Leite AZ; Sipahi AM; Damião AO; Coelho AM; Garcez AT; Machado MC; Buchpiguel CA; Lopasso FP; Lordello ML; Agostinho CL; Laudanna AA
    Gut; 2001 Feb; 48(2):163-7. PubMed ID: 11156635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
    Somasundaram S; Rafi S; Hayllar J; Sigthorsson G; Jacob M; Price AB; Macpherson A; Mahmod T; Scott D; Wrigglesworth JM; Bjarnason I
    Gut; 1997 Sep; 41(3):344-53. PubMed ID: 9378390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.
    Tibble JA; Sigthorsson G; Foster R; Bjarnason I
    Scand J Gastroenterol; 2000 Aug; 35(8):802-7. PubMed ID: 10994617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pathogenic events in NSAID-induced gastrointestinal damage.
    Bjarnason I; Hayllar J
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():19-22. PubMed ID: 9032577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a selective nonsteroidal anti-inflammatory inhibitor of cyclooxygenase-2 on the small bowel of rats.
    Leite AZ; Sipahi AM; Damião AO; Garcez AT; Buchpiguel CA; Lopasso FP; Lordello ML; Agostinho CL; Laudanna AA
    Braz J Med Biol Res; 2004 Mar; 37(3):333-6. PubMed ID: 15060699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.
    Sigthorsson G; Simpson RJ; Walley M; Anthony A; Foster R; Hotz-Behoftsitz C; Palizban A; Pombo J; Watts J; Morham SG; Bjarnason I
    Gastroenterology; 2002 Jun; 122(7):1913-23. PubMed ID: 12055598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat.
    Walley M; Sigthorsson G; Hotz-Behofsits C; Simpson R; Bjarnason I
    Inflammopharmacology; 2007 Jun; 15(3):119-23. PubMed ID: 19847952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
    Bjarnason I; Takeuchi K
    J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2.
    Yáñez JA; Teng XW; Roupe KA; Fariss MW; Davies NM
    J Pharm Pharm Sci; 2003; 6(3):308-14. PubMed ID: 14738710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
    Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
    J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
    Ligumsky M; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
    Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
    Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
    LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
    Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.